Age at menopause and its influencing factors in a cohort of survivors of childhood cancer: Earlier but rarely premature

Human Reproduction

Volumn 28, Issue 2, 2013, Pages 488-495

  Thomas Teinturier, Cécile ^a,b   El Fayech, Chiraz ^a,c,d   Oberlin, Odile ^a,c   Pacquement, Hélène ^e   Haddy, Nadia ^a,c,d   Labbé, Martine ^a,c,d   Veres, Cristina ^a,c,d   Guibout, Catherine ^a,c,f   Diallo, Ibrahima ^a,c,d   De Vathaire, Florent ^a,c,d  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b BICÊTRE HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e INSTITUT CURIE   (France)

^f PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

alkylating agents; childhood cancer; menopause; radiotherapy; survivors

Indexed keywords

CYCLOPHOSPHAMIDE; PROCARBAZINE; SARCOLYSIN;

ADULT; AGE; ARTICLE; CANCER SURVIVOR; CHILDHOOD CANCER; DRUG EXPOSURE; EARLY MENOPAUSE; FEMALE; FOLLOW UP; HUMAN; MULTICENTER STUDY; OVARIECTOMY; RADIATION DOSE; RISK FACTOR;

EID: 84872588330     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des391     Document Type: Article

References (25)

1. Birch J, Marsden HA. Classification scheme for childhood cancer. Int J Cancer 1987;40: 620-624.
2. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB, Meigs JW et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992;166: 788-793.
3. Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA. Acute ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2006;91: 1723-1728.
4. Chiarelli AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 1999;150: 245-254.
5. Couto-Silva AC, Trivin C, Thibaud E, Esperou H, Michon J, Brauner R. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant 2001;28: 67-75.
6. Cox D. Regression models and life tables. J Royal Stat Soc 1972; 20: 187-220.
7. De Bruin ML, Huisbrink J, Hauptmann M, Kuenen MA, Ouwens GM, van't Veer MB, Aleman BM, van Leeuwen FE. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood 2008; 111: 101-108.
8. De Vathaire F, Hawkins M, Cambell S, Oberlin O, Raquin MA, Schlienger JY, Shamsaldin A, Diallo I, Bell J, Grimaud E. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 1999;79: 1884-1893.
9. Desandes E, Berger C, Tron I, Demeocq F, Bellec S, Blouin P, Casagranda L, De Lumley L, Freycon F, Goubin A et al. Childhood cancer survival in France, 1990-1999. Eur J Cancer 2008;44: 205-215.
10. Diallo I, Lamon A, Shamsaldin A, Grimaud E, de Vathaire F, Chavaudra J. Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol 1996;38: 269-271.
11. Dratva J, Gomez Real F, Schindler C, Ackermann-Liebrich U, Gerbase MW, Probst-Hensh NM, Svanes C, Omenaas ER, Neukirch F, Wjst M et al. Is age at menopause increasing across Europe? Results on age at menopause and determinants from 2 population-based studies. Menopause 2009;16: 385-394.
12. François P, Beurtheret C, Dutreix A. Calculation of dose delivered to organs outside the radiation beams. Med Phys 1988a;15: 879-883.
13. François P, Beurtheret C, Dutreix A, De Vathaire F. A mathematical child phantom for the calculation of dose to the organs at risk. Med Phys 1988b;15: 328-333.
14. Hardy R, Kuh D. Reproductive characteristics and the age at inception of the perimenopause in a British National cohort. Am J Epidemiol 1999; 149: 612-620.
15. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003;18: 199-206.
16. Michel G, Socie G, Gebhard F, Bernaudin F, Thuret I, Vannier JP, Demeocq F, Leverger G, Pico JL, Rubie H. Late effects of allogenic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation. A report from the Société Française de Greffe de Moelle. J Clin Oncol 1997;15: 2238-2246.
17. Preston DL, Lubin JH, Pierce DA. EPICURE User's Guide. Seattle, WA, USA: Hirosoft International Corporation, 1993.
18. Sarafoglou K, Boulad F, Gillio A, Sklar CA. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997;130: 210-216.
19. Shamsaldin A, Grimaud E, Hardiman C, Diallo I, de Vathaire F, Chavaudra J. Dose distribution throughout the body from radiotherapy for Hodgkin's diseases in childhood. Radiother Oncol 1998;49: 85-90.
20. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006;98: 890-896.
21. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, RoccaWA. Premature menopause or early menopause: long term health consequences. Maturitas 2010;62: 161-166.
22. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougnères PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998;22: 989-994.
23. Van Noord PAH, Dubas JS, Dorland M, Boersma H, Te Velde E. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril 1997;68: 95-102.
24. Wallace WH, Thomson AB, Kesley TW. The radiosensitivity of the human oocyte. Hum Reprod 2003;18: 117-121.
25. Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 1983; 52: 988-993.